We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 26 oktober 2017

The Lancet: [Department of Error] Department of Error

[Department of Error] Department of Error
Garg SK, Polsky S. Continuous glucose monitoring in pregnant women with type 1 diabetes. Lancet 2017; published online Sept 15. http://dx.doi.org/10.1016/S0140-6736(17)32449-2— This Comment should have been published under a Creative Commons CC BY 4.0 open-access license. This correction has been made to the online version as of Oct 20, 2017, and will be made to the printed Comment.
Read more

[Department of Error] Department of Error
Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017; published online Sept 15. http://dx.doi.org/10.1016/S0140-6736(17)32400-5—This Article should have been published under a Creative Commons CC BY 4.0 open-access license. In the author list, Elizabeth Asztalos was spelled incorrectly. These corrections have been made to the online version as of Oct 20, 2017, and will be made to the printed Article.
Read more

[Comment] Continued conundrum of PET-CT and Hodgkin's lymphoma
In advanced-stage Hodgkin's lymphoma, several trials using a PET response-adapted therapy have been published.1–3 The aim of these trials is to discriminate between patients at low or high risk of relapse using PET response as a surrogate for treatment sensitivity. The strategy is to de-escalate treatment in patients predicted to be good responders to minimise toxicity or escalate treatment in predicted poor responders to improve progression-free survival for those who need it the most.
Read more

[Comment] Hypertension in China: the gap between policy and practice
The high prevalence of hypertension in China is well known, with stroke being the most common cause of death and disability.1 Two large nationwide studies reported in The Lancet2,3 highlight that although the prevalence of hypertension in China is similar to that suggested in previous studies, it is simple deficiencies in the country's health system that make a large contribution to the disease burden. Both studies used data from the PEACE (Patient-Centred Evaluative Assessment of Cardiac Events) Million Persons Project (MPP), which enrolled 1·7 million adults aged 35–75 years from across China.
Read more

[Articles] Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)
Among Chinese adults aged 35–75 years, nearly half have hypertension, fewer than a third are being treated, and fewer than one in twelve are in control of their blood pressure. The low number of people in control is ubiquitous in all subgroups of the Chinese population and warrants broad-based, global strategy, such as greater efforts in prevention, as well as better screening and more effective and affordable treatment.
Read more